Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Godollo – page 62

1 108 clinical trials in Godollo, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Godollo at a glance
1 108
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 108 trials in Godollo

Open in trial search

Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Exelixis Inc.

Fallopian tube cancer+2

Not recruiting

Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Relacorilant
  • Sponsor:Corcept Therapeutics Inc.

Study on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Bergenbio ASA

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Astrazeneca AB

Acute kidney injury

Not recruiting

Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:TIN816
  • Sponsor:Novartis Pharma AG

Neoplasm malignant

Not recruiting

Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Avelumab
  • Sponsor:Pfizer Inc.

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Acute myeloid leukaemia+10

Not recruiting

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Diabetic retinal oedema+1

Not recruiting

Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Godollo

What the registry says about research in the country

01 Respiratory Disease Research

Extensive research focusing on chronic obstructive pulmonary disease (COPD) and various treatment approaches, including triple therapy combinations and novel bronchodilators. Studies evaluate the effectiveness of different medications in reducing exacerbations and improving lung function.

  • COPD Treatment Evaluation
  • Bronchodilator Studies
  • Exacerbation Management

Multiple trials examining long-term safety and efficacy of innovative therapies for moderate to severe COPD patients.

02 Asthma Management Studies

Comprehensive research into severe asthma treatments, including investigations of new biological therapies and innovative inhaler formulations. Studies focus on reducing exacerbations and improving control in patients with moderate to severe asthma.

  • Severe Asthma Therapeutics
  • Biological Treatment Options
  • Pediatric Asthma Care

Clinical trials exploring both established and novel treatment approaches for various asthma phenotypes.

03 Specialized Respiratory Conditions

Targeted research addressing eosinophilic asthma and chronic cough conditions. Studies evaluate innovative treatments including long-acting medications and targeted therapies for specific patient populations.

  • Refractory Chronic Cough
  • Eosinophilic Disease Management
  • Long-term Treatment Safety

Investigations focus on developing specialized treatments for patients with specific respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.